DOX vs EPAM
Amdocs Ltd. and Epam Systems, Inc., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | DOX | EPAM |
|---|---|---|
| Revenue | $5.0B | $5.5B |
| Net income | $493.2M | $377.7M |
| Gross margin | 35.1% | 28.8% |
| Net margin | 9.9% | 6.9% |
| Return on equity | 14.1% | 10.3% |
| Diluted EPS | $4.25 | $6.72 |
| Dividend / share | $1.87 | · |
| Payout ratio | 43.0% | · |
| Free cash flow | $618.9M | $612.7M |
| Equity | $3.5B | $3.7B |
| Net debt / equity | 0.09× | −0.35× |
| Current ratio | 1.20× | 2.59× |
| Revenue CAGR 5y | 4.1% | 15.5% |
| Profit CAGR 5y | 0.6% | 2.9% |
DOX and EPAM book revenue within 15% of each other, and keeps more of each dollar of revenue as profit (9.9% against 6.9%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
10 years side by side
| Fiscal year | DOX | EPAM |
|---|---|---|
| FY2024 | $5.0B | $4.7B |
| FY2023 | $4.9B | $4.7B |
| FY2022 | $4.6B | $4.8B |
| FY2021 | $4.3B | $3.8B |
| FY2020 | $4.2B | $2.7B |
| FY2019 | $4.1B | $2.3B |
| FY2018 | $4.0B | $1.8B |
| FY2017 | $3.9B | $1.5B |
| FY2016 | $3.7B | $1.2B |
| FY2015 | $3.6B | $914.1M |
Bottom line
| Fiscal year | DOX | EPAM |
|---|---|---|
| FY2024 | $493.2M | $454.5M |
| FY2023 | $540.7M | $417.1M |
| FY2022 | $549.5M | $419.4M |
| FY2021 | $688.4M | $481.7M |
| FY2020 | $497.8M | $327.2M |
| FY2019 | $479.4M | $261.1M |
| FY2018 | $354.4M | $240.3M |
| FY2017 | $436.8M | $72.8M |
| FY2016 | $409.3M | $99.3M |
| FY2015 | $446.2M | $84.5M |
15 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2024 | +$277,049,000 | DOX |
| FY2023 | +$197,010,000 | DOX |
| FY2022 | −$248,001,000 | EPAM |
| FY2021 | +$530,496,000 | DOX |
| FY2020 | +$1,509,561,000 | DOX |
| FY2019 | +$1,792,871,000 | DOX |
| FY2018 | +$2,131,925,000 | DOX |
| FY2017 | +$2,416,707,000 | DOX |
| FY2016 | +$2,558,097,000 | DOX |
| FY2015 | +$2,729,410,000 | DOX |
| FY2014 | +$2,833,610,000 | DOX |
| FY2013 | +$2,790,737,000 | DOX |
| FY2012 | +$2,692,661,000 | DOX |
| FY2011 | +$2,723,963,000 | DOX |
| FY2010 | +$2,661,432,000 | DOX |
The higher-revenue side has changed between DOX and EPAM over this period. The gap has narrowed since the earliest year compared.
15 of 19 comparable fiscal years — a year missing data on either side is not counted.
15 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2024 | +0.3 pp | DOX |
| FY2023 | +2.2 pp | DOX |
| FY2022 | +3.3 pp | DOX |
| FY2021 | +3.2 pp | DOX |
| FY2020 | −0.4 pp | EPAM |
| FY2019 | +0.4 pp | DOX |
| FY2018 | −4.1 pp | EPAM |
| FY2017 | +6.3 pp | DOX |
| FY2016 | +2.5 pp | DOX |
| FY2015 | +3.0 pp | DOX |
| FY2014 | +2.3 pp | DOX |
| FY2013 | +1.2 pp | DOX |
| FY2012 | −0.0 pp | EPAM |
| FY2011 | −1.9 pp | EPAM |
| FY2010 | −0.8 pp | EPAM |
The higher net margin has changed hands between DOX and EPAM over this period.
15 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
EPAM's net margin has been more volatile than DOX's over the 15 comparable fiscal years — 2.3 percentage points of standard deviation against 1.5.
15 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between DOX and EPAM over these 15 fiscal years — DOX led in 10 and EPAM in 5.
15 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
EPAM's return on equity has been more volatile than DOX's over the 15 comparable fiscal years — 16.0 percentage points of standard deviation against 2.1.
15 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between DOX and EPAM over these 15 fiscal years — DOX led in 4 and EPAM in 11.
15 of 19 comparable fiscal years — a year missing data on either side is not counted.